Digital AI is reshaping drug discovery - Now it must prove it can be... As innovation pushes the boundaries of speed and scale, a question remains: can we use transparency as a way to prove safety and build public trust?
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.